Track and Trace Service for securing Drug Products launched

Pharmaceutical Industries first track and trace (#Supplychain) solution designed to secure drug products against counterfeiting and diversion threats such as the recent Avastin incident. TraceLink has developed this solution combining drug traceability, secure chain of custody, mobile/enterprise drug authentication and serialization/EPCIS event management.

Using the above mentioned facilities, TraceLink Track and Trace helps companies across the Life Sciences supply chain ensure product security, protect patient safety and maintain regulatory compliance. TraceLink Inc. also developed the world’s first industry-wide supply collaboration and product traceability network, TraceLink Network.

Recently they announced the launch of their new global Track and Trace product family. Built upon the company’s history as a leader in ePedigree and pharmaceutical authentication solutions, TraceLink’s Track and Trace application platform provides comprehensive capabilities for drug traceability, secure chain of custody, serialization data/EPCIS event management, channel and consumer mobile authentication along with governmental reporting.

The TraceLink Network for Track and Trace is a cloud-based application platform for all companies involved in the production and distribution of pharmaceuticals including pharma/biopharmaceutical companies, contract manufacturers/packagers, 3PLs, wholesale distributors, pharmacies, hospitals, clinics and patients.

TraceLink’s Track and Trace solutions join the company’s existing Supply Collaboration solutions to help manage and improve the performance of external supply and outsourced production operations.

Michael Lee, VP, Manufacturing, Biomabs Pharmaceuticals, China, will be presenting at the Pharma and Biotech Supply Chain World Asia 2012 this March about "Balancing Flexibility in cold chain movements with retention of the integrity and quality of pharmaceuticals."

Click here to register your attendance at this conference now.

Leave a Reply

Your email address will not be published. Required fields are marked *